Abstract

In this study, the catalytic properties of Fenton-like catalyst based on magnesium ferrite nanoparticles for IBP degradation were examined. Structural and morphological studies showed the low crystallinity and mesoporous structure for the catalyst obtained via a glycine-nitrate method. The influences of catalyst dosage, oxidant concentration, and solution pH on the pollutant degradation were investigated. The pseudo-first-order model describes kinetic data, and under optimal condition (catalyst dose of 0.5 g L-1, H2O2 concentration of 20.0 mM, and pH of 8.0), apparent rate constant reached 0.091 min-1. It was shown that Fenton reaction was mainly induced by iron atoms on the catalyst surface, which is supported by very low iron leaching (up to 0.05 mg L-1) and high catalytic activity at neutral solution pH (6.0-8.0). It was found that the IBP mineralization onto magnesium ferrite catalyst was rapid and reached up to 98-100% within 40 min. Thus, prepared magnesium ferrite nanoparticles can be used as an effective Fenton-like catalyst for the IBP degradation from wastewater.

Highlights

  • Ibuprofen (IBP) is a nonsteroidal anti-inflammatory drug, which is widely used to treat fever, pain, and inflammation of minor injury

  • The catalytic properties of Fenton-like catalyst based on magnesium ferrite nanoparticles for IBP degradation were examined

  • It was shown that Fenton reaction was mainly induced by iron atoms on the catalyst surface, which is supported by very low iron leaching and high catalytic activity at neutral solution pH (6.0-8.0)

Read more

Summary

Introduction

Ibuprofen (IBP) is a nonsteroidal anti-inflammatory drug, which is widely used to treat fever, pain, and inflammation of minor injury. IBP was the first member of propionic acid derivatives introduced in 1969. It is used as an analgesic and antipyretic drug for adults and children. IBP was rated as the safest conventional nonsteroidal anti-inflammatory drug by spontaneous adverse drug reaction reporting systems in the UK [1]. The high annual consumption is about 200 tons per year, and low metabolite conversion of IBP in the human body leads to the presence of IBP derivatives in the wastewater treatment plant, in surface water, and even in drinking water [2]. Ingestion of IBP in the environment leads to significant negative consequences. The municipal wastewater treatment plant, common water treatment processes, such as coagulation/flocculation and filtration, and biological treatment do not remove efficiently the pharmaceuticals and Molecule structure image

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call